Assertio (ASRT) announced that it filed a certificate of amendment to its certificate of incorporation on December 19 to implement a one-for-fifteen reverse split of its issued and outstanding common stock. The reverse split will become effective as of 12:01 a.m. Eastern Time on December 26 and the company’s common stock will begin trading on a split-adjusted basis when the market opens on December 26. The company’s common stock will continue to trade on Nasdaq under the same symbol.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASRT:
- Assertio Therapeutics Announces Leadership Change with CEO Resignation
- Assertio Therapeutics: Strategic Moves and Leadership Changes Drive Buy Rating
- Assertio Therapeutics Reports Strong Q3 Earnings Amid Rolvedon Growth
- Assertio Therapeutics Reports Strong Q3 2025 Results
- Assertio Therapeutics Promotes Paul Schwichtenberg to President